Bone biology

Understanding bone biology

Bone is not an inert scaffold. It is living, vascular, mineralized tissue that senses load, repairs microdamage, stores minerals, houses marrow, and continuously rebuilds itself through coordinated cellular and molecular signaling.

The big picture: bone from organ to molecule

Bone biology can be understood in layers. At the gross level, a long bone contains cortical bone, trabecular bone, marrow, periosteum, endosteum, blood vessels, and nerves. At the microscopic level, compact bone is organized into osteons, lamellae, lacunae, and canaliculi. At the molecular level, collagen, hydroxyapatite, RANK/RANKL/OPG, WNT signaling, sclerostin, cytokines, and hormones help determine whether bone is being built, maintained, or resorbed.12

Diagram moving from whole femur to femur cross-section, cortical bone, single osteon, and osteocytes in lacunae.
Bone organization from the whole femur to microscopic osteocytes connected by canaliculi.
Key takeaway: Bone strength is not just bone density. Strength also depends on structure, microarchitecture, collagen quality, mineralization, remodeling balance, and how well bone cells communicate.

Gross structure: cortical bone, trabecular bone, marrow, and periosteum

Cortical bone is the dense outer shell that gives long bones much of their bending and torsional strength. Trabecular, or cancellous, bone forms an internal lattice that is metabolically active and responsive to loading. The periosteum covers the outer bone surface and contains nerves, vessels, and progenitor cells; the endosteum lines inner surfaces where remodeling is also active.12

Cutaway drawing of compact bone showing periosteum, osteons, central canals, osteocytes, lacunae, canaliculi, spongy bone, blood vessels, and nerve.
Compact bone is organized into osteons around central canals, while spongy bone uses trabecular struts.
Detailed drawing of an osteon central canal with artery, vein, nerve, lamellae, lacunae, canaliculi, and osteocyte in lacuna.
Each osteon is built around a central canal carrying blood vessels and nerves.
Cortical bone Dense, organized bone with osteons. It is especially important in the shafts of long bones.
Trabecular bone A lattice of plates and rods. It has a large surface area, so remodeling changes can appear quickly.
Marrow space Contains hematopoietic and stromal cells. The marrow environment communicates with bone cells.
Periosteum and endosteum Living surfaces where cells can build, line, repair, and remodel bone.

Microstructure: osteons, lamellae, lacunae, and canaliculi

An osteon, also called a Haversian system, is a cylindrical structural unit of cortical bone. Concentric lamellae are rings of mineralized matrix surrounding a central canal. Osteocytes sit in lacunae between lamellae and extend processes through canaliculi, allowing cell-to-cell communication and fluid-flow sensing.134

Microscopic view of an osteon with Haversian channel, osteocytes, lamellae, and canaliculi labeled.
A microscopic osteon: concentric lamellae surround the Haversian canal, with osteocytes housed in lacunae.
Diagram of an osteon showing Haversian canal, lacuna, canaliculus, concentric lamellae, cement line, and an osteocyte in a lacuna.
Osteocytes live inside lacunae and communicate through canaliculi, forming a living sensor network inside bone.
Why canaliculi matter: osteocytes are trapped inside mineralized matrix, but they are not isolated. Their canalicular network helps them sense strain, detect microdamage, regulate mineral metabolism, and signal to osteoblasts and osteoclasts.3410

The matrix: collagen plus mineral, not just calcium

Bone matrix begins as osteoid, an organic matrix made mainly of type I collagen. Mineralization then deposits hydroxyapatite crystals into and around that collagen scaffold. Collagen gives bone toughness and resistance to cracking; mineral gives stiffness and compressive strength.111

Bone matrix from collagen to mineral Type I collagen forms an organic scaffold, noncollagen proteins organize mineralization, and hydroxyapatite crystals stiffen the matrix. Type I collagen flexible scaffold osteoid Matrix proteins osteocalcin, osteopontin, ALP, proteoglycans Hydroxyapatite calcium-phosphate mineral crystals Bone strength comes from both parts: collagen provides toughness; mineral provides stiffness. Problems in either side can weaken bone quality.
Bone matrix is not just calcium. It is a mineralized collagen-based composite with many regulatory proteins.111

Bone remodeling: how bone renews itself

Adult bone is renewed by basic multicellular units. Osteoclasts resorb older or damaged bone, reversal cells help prepare the surface, and osteoblasts refill the cavity with new osteoid that later mineralizes. This remodeling process repairs microdamage and helps calcium-phosphate homeostasis, but it can weaken bone if resorption repeatedly outpaces formation.25

1. Activation Osteocytes and surface cells detect microdamage, stress, hormones, or inflammatory signals.
2. Resorption Osteoclasts attach to bone and dissolve mineral and collagen matrix.
3. Reversal The surface is cleaned and prepared; coupling signals recruit osteoblast-lineage cells.
4. Formation Osteoblasts lay down osteoid, especially type I collagen-rich matrix.
5. Mineralization Hydroxyapatite hardens the new matrix over time.

Bone cells and what they do

CellOrigin / locationMain functionImportant signals
Osteoprogenitor / mesenchymal stromal cellPeriosteum, endosteum, marrow stromal compartmentPrecursor pool for osteoblast-lineage cells; responds to mechanical and hormonal signals.RUNX2, SP7/osterix, BMPs, WNT, PTH/PTH1R
OsteoblastBone-forming surface cell from mesenchymal lineageProduces osteoid, type I collagen, alkaline phosphatase, and mineralization-regulating proteins.WNT/beta-catenin, RUNX2, SP7, BMPs, ALPL, BGLAP, SPP1
OsteocyteFormer osteoblast embedded in lacunaeMost abundant mature bone cell; senses mechanical load, regulates mineral metabolism, and coordinates remodeling.SOST/sclerostin, RANKL, FGF23, connexins, nitric oxide, prostaglandins
Bone lining cellFlattened quiescent osteoblast-lineage cell on bone surfacesCovers resting surfaces; can help regulate access to mineralized surface and participate in remodeling activation.RANKL/OPG balance, PTH response, local coupling signals
Osteoclast precursorHematopoietic monocyte-macrophage lineageFuses into multinucleated osteoclasts when exposed to key differentiation signals.M-CSF, RANK, RANKL, NF-kB, NFATc1
OsteoclastMultinucleated hematopoietic-lineage cell on bone surfaceResorbs bone by acidifying the sealed resorption zone and degrading matrix.RANKL, integrins, cathepsin K, TRAP, calcitonin receptor
ChondrocyteCartilage cell, especially growth plate and fracture callus contextsBuilds cartilage matrix; participates in endochondral ossification during growth and repair.SOX9, Indian hedgehog, PTHrP, collagen type II and X
Immune and marrow cellsBone marrowInfluence remodeling through inflammatory cytokines and marrow-bone crosstalk.IL-1, IL-6, TNF-alpha, interferons, RANKL

RANK, RANKL, and osteoprotegerin: the osteoclast control system

RANKL is a key signal made by osteoblast-lineage cells and osteocytes. It binds RANK on osteoclast precursors and activates downstream pathways that drive osteoclast differentiation, activation, and survival. Osteoprotegerin, abbreviated OPG, is a soluble decoy receptor that binds RANKL and prevents it from activating RANK.67

RANK, RANKL, and osteoprotegerin signaling Osteoblast-lineage cells and osteocytes make RANKL and M-CSF. RANKL binds RANK on osteoclast precursors. OPG acts as a decoy receptor and blocks RANKL. Osteocyte / osteoblast lineage releases RANKL and M-CSF Osteoclast precursor RANK receptor on cell surface RANKL Mature osteoclast resorbs mineral and collagen matrix TRAF6, NF-kB, NFATc1 OPG decoy receptor More RANKL signal favors osteoclast formation. More OPG buffers the signal. Big idea: RANKL is the “go” signal for osteoclasts; osteoprotegerin (OPG) is a protective decoy that can soak up RANKL before it reaches RANK.
RANK/RANKL/OPG is the core signaling system that controls osteoclast formation and survival.67

Cell-level detail: RANK signaling from membrane to nucleus to matrix resorption

Detailed RANKL to RANK osteoclast signaling map The diagram separates extracellular RANKL, OPG and M-CSF signals, osteoclast precursor cell-surface receptors, cytoplasmic TRAF6, NF-kB, MAPK and calcium signaling, nuclear NFATc1-driven transcription, and matrix resorption by the mature osteoclast. RANKL/RANK/OPG pathway Teaching map of the core compartments; many molecular details are simplified. Extracellular space RANKL from osteocyte / osteoblast M-CSF survival signal OPG decoy binds RANKL OPG can bind RANKL before RANKL reaches RANK. Cell surface RANK c-Fms / CSF1R Cytoplasm TRAF6 scaffold RANK tail signal IKK – NF-kB survival / priming MAPK – AP-1 c-Fos program Ca2+ / calcineurin NFATc1 activation Nucleus NF-kB + AP-1 + NFATc1 NFATc1 auto-amplification Osteoclast genes: CTSK, ACP5/TRAP, DCSTAMP ATP6V0D2, ITGB3, TCIRG1 Fusion + polarization multinucleated osteoclast actin sealing zone ruffled border Extracellular matrix / resorption lacuna Hydroxyapatite mineral + type I collagen matrix ruffled border V-ATPase / H+ CTSK Main idea: RANK signaling writes the osteoclast program; mature cells use acid and cathepsin K at bone matrix.
Detailed cellular map of RANKL-driven osteoclastogenesis and resorption. It shows the ligand/receptor step, cytoplasmic TRAF6 signaling, NFATc1-centered nuclear gene expression, and the mature osteoclast’s ruffled-border machinery at the bone matrix.671314
Key: RANKL = receptor activator of nuclear factor kappa-B ligand (TNFSF11 protein/gene); RANK = receptor activator of nuclear factor kappa-B (TNFRSF11A receptor/gene); OPG = osteoprotegerin, a soluble RANKL decoy receptor (TNFRSF11B); M-CSF = macrophage colony-stimulating factor, also called CSF1 (CSF1 protein/gene); c-Fms = M-CSF receptor (CSF1R protein/gene); TRAF6 = TNF receptor-associated factor 6 adapter; IKK = IkB kinase complex; NF-kB = nuclear factor kappa-B transcription-factor family; MAPK = mitogen-activated protein kinase pathway; AP-1 = activator protein-1 transcription-factor complex; c-Fos = FOS protein/gene component of AP-1; Ca2+ = calcium signal; calcineurin = calcium-dependent phosphatase; NFATc1 = nuclear factor of activated T-cells c1 (NFATC1 protein/gene); CTSK = cathepsin K; ACP5/TRAP = tartrate-resistant acid phosphatase; DCSTAMP = dendritic cell-specific transmembrane protein; ATP6V0D2 = vacuolar ATPase V0 subunit d2; ITGB3 = beta-3 integrin; TCIRG1 = vacuolar proton-pump a3 subunit; V-ATPase/H+ = vacuolar ATPase proton pump; ruffled border and actin sealing zone = osteoclast resorption structures; type I collagen = COL1A1/COL1A2 collagen matrix.
RANKL high More osteoclast formation and activity are favored.
OPG high RANKL is buffered, so osteoclast signaling is restrained.
PTH and vitamin D context These can influence RANKL/OPG balance depending on timing and physiology.
Inflammation context Cytokines can push remodeling toward more resorption in some disease states.

WNT, LRP5/6, beta-catenin, and sclerostin: the bone-formation gate

Canonical WNT signaling helps osteoblast-lineage cells commit to bone formation and supports osteoblast function. WNT ligands signal through Frizzled receptors and LRP5/6 coreceptors, allowing beta-catenin to accumulate and activate bone-forming gene programs. Sclerostin, encoded by the SOST gene and produced mainly by osteocytes, inhibits LRP5/6 and restrains bone formation.89

Canonical WNT signaling in osteoblast-lineage cells WNT binds Frizzled and LRP5/6, stabilizes beta-catenin, and supports osteoblast activity. Sclerostin and DKK1 inhibit the receptor complex. WNT ligand outside cell Frizzled + LRP5/6 cell-surface receptor beta-catenin stabilized Osteoblast matrix genes Sclerostin from osteocytes DKK1 inhibitor Big idea: WNT signaling helps osteoblast-lineage cells build bone. Sclerostin, made mainly by osteocytes, restrains this pathway by inhibiting LRP5/6. Mechanical loading and intermittent PTH signaling tend to lower sclerostin, opening the gate for formation.
Canonical WNT signaling supports bone formation; sclerostin and DKK1 are important brakes on that pathway.89

Cell-level detail: WNT signaling from matrix environment to nuclear bone-formation genes

Detailed WNT beta-catenin osteoblast-lineage signaling map The diagram separates extracellular WNT, sclerostin and DKK1 signals, the Frizzled and LRP5/6 receptor complex, cytoplasmic beta-catenin stabilization, nuclear TCF/LEF transcription, and secretion of osteoid and mineralization proteins into extracellular matrix. WNT/LRP5/6/beta-catenin: matrix -> receptor -> cytoplasm -> nucleus -> osteoid Extracellular inhibitors restrain LRP5/6; beta-catenin controls transcription. Extracellular space near osteoblast-lineage cell WNT Sclerostin DKK1 Osteocyte-derived sclerostin and DKK1 restrain LRP5/6 signaling. Cell surface: osteoblast-lineage cell Frizzled LRP5/6 Cytoplasm Dishevelled + Axin receptor complex forms Destruction complex APC, Axin, GSK3, CK1 held off when WNT is on Beta-catenin stabilizes and accumulates Nucleus Beta-catenin + TCF/LEF cooperates with osteoblast programs RUNX2, SP7/osterix COL1A1, ALPL, BGLAP OPG/RANKL balance Osteoblast output osteoid + mineralization local coupling signals Extracellular matrix / osteoid surface Type I collagen scaffold, osteocalcin/osteopontin, alkaline phosphatase activity, hydroxyapatite mineral deposition Collagen I ALP Main idea: WNT stabilizes beta-catenin for osteoblast gene expression and matrix formation.
Detailed cellular map of canonical WNT signaling in an osteoblast-lineage cell. It shows extracellular WNT and WNT inhibitors, the Frizzled-LRP5/6 surface complex, cytoplasmic beta-catenin stabilization, nuclear TCF/LEF transcription, and matrix protein output.891516

That is why osteocytes are so important: they do not simply sit inside bone. They help decide whether the local skeleton should build, conserve, or remodel. Mechanical loading and intermittent parathyroid hormone signaling tend to reduce sclerostin, while unloading tends to favor signals that reduce formation.3810

Molecules, proteins, collagens, cytokines, and pathways

Molecule / pathwayCategoryPlain-English role in bone
Type I collagen (COL1A1/COL1A2)Structural matrix proteinMain organic scaffold of bone; contributes toughness and crack resistance.
HydroxyapatiteMineral crystalCalcium-phosphate crystal that stiffens the collagen matrix.
Alkaline phosphatase (ALPL)Mineralization enzyme / formation markerSupports mineralization; bone-specific alkaline phosphatase is a formation marker.
Osteocalcin (BGLAP)Noncollagen bone matrix proteinOsteoblast product associated with mineralized matrix and bone formation.
Osteopontin (SPP1)Matrix glycoproteinHelps regulate cell attachment and mineral-matrix interactions.
Osteonectin / SPARCMatrix glycoproteinBinds collagen and mineral; helps organize mineralized matrix.
RANKL (TNFSF11)Osteoclast differentiation cytokineKey “go” signal for osteoclast formation and survival.
RANK (TNFRSF11A)ReceptorReceptor on osteoclast precursors that receives the RANKL signal.
Osteoprotegerin / OPG (TNFRSF11B)Decoy receptorBinds RANKL before it reaches RANK, reducing osteoclast signaling.
M-CSF (CSF1)Growth factorSupports osteoclast precursor survival and differentiation.
NF-kB and NFATc1Transcription signalingDownstream RANK signals that help drive osteoclast gene programs.
WNT ligandsFormation pathway signalPromote osteoblast-lineage commitment and bone formation signaling.
LRP5/6 and FrizzledWNT receptor complexReceives WNT signals at the cell surface.
Beta-catenin (CTNNB1)Canonical WNT effectorMoves into the nucleus when WNT signaling is active and supports bone-forming gene expression.
Sclerostin (SOST)Osteocyte-derived WNT inhibitorActs as a brake on bone formation by inhibiting LRP5/6.
DKK1WNT inhibitorAnother inhibitor of LRP5/6-mediated WNT signaling.
RUNX2 and SP7/osterixOsteoblast transcription factorsHelp immature cells commit to the osteoblast lineage.
BMPsGrowth factorsPromote osteoblast differentiation and matrix production in many contexts.
TGF-betaGrowth factor released from matrixParticipates in coupling resorption to formation and cell recruitment.
IL-1, IL-6, TNF-alphaInflammatory cytokinesCan increase resorption signaling in inflammatory states.
PTH / PTH1RHormone and receptorRegulates calcium and remodeling; intermittent and continuous exposure have different skeletal effects.
FGF23Osteocyte hormoneHelps regulate phosphate and vitamin D metabolism through kidney signaling.
PINP, CTX, TRAP, DPDBone turnover markersBlood or urine markers that reflect formation or resorption activity, not structure by themselves.

This table is a teaching map, not a complete molecular atlas. Bone biology involves many additional genes, receptors, enzymes, and local signals.181112

How to read bone biology clinically

Bone density tests estimate mineral content, but a living skeleton is more complicated than a number. A useful clinical view asks about architecture, turnover, nutrition, hormones, kidney function, medications, inflammation, muscle, falls, and prior fracture history. The molecular pathways above are not meant to make the page a treatment guide; they explain why bone can change over time and why different bone conditions may need different conversations.

Structure Cortical thickness, trabecular connectivity, osteon organization, and microdamage all matter.
Cells Osteoblasts, osteoclasts, and osteocytes have to stay coordinated.
Signals RANKL/OPG and WNT/sclerostin are two central control systems.

Keep learning

Bone, Muscle & Mobility Osteoporosis basics Understanding a DEXA scan Tools & Article Library

About this page

This page is educational and is not medical advice. It is meant to help patients and interested readers understand the basic structure, cells, and molecular pathways of bone before discussing personal risk, testing, or treatment decisions with a clinician.

References

  1. Florencio-Silva R, Sasso GR, Sasso-Cerri E, Simoes MJ, Cerri PS. Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells. Biomed Res Int. 2015;2015:421746. doi:10.1155/2015/421746. PMID: 26247020. PubMed
  2. Siddiqui JA, Partridge NC. Physiological Bone Remodeling: Systemic Regulation and Growth Factor Involvement. Physiology (Bethesda). 2016;31(3):233-245. doi:10.1152/physiol.00061.2014. PMID: 27053737. PubMed
  3. Robling AG, Bonewald LF. The Osteocyte: New Insights. Annu Rev Physiol. 2020;82:485-506. doi:10.1146/annurev-physiol-021119-034332. PMID: 32040934. PubMed
  4. Schaffler MB, Cheung WY, Majeska R, Kennedy O. Osteocytes: master orchestrators of bone. Calcif Tissue Int. 2014;94(1):5-24. doi:10.1007/s00223-013-9790-y. PMID: 24042263. PubMed
  5. Delaisse JM. The reversal phase of the bone-remodeling cycle: cellular prerequisites for coupling resorption and formation. Bonekey Rep. 2014;3:561. doi:10.1038/bonekey.2014.56. PMID: 25120911. PubMed
  6. Boyce BF, Xing L. Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys. 2008;473(2):139-146. doi:10.1016/j.abb.2008.03.018. PMID: 18395508. PubMed
  7. Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003;423(6937):337-342. doi:10.1038/nature01658. PMID: 12748652. PubMed
  8. Baron R, Kneissel M. WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med. 2013;19(2):179-192. doi:10.1038/nm.3074. PMID: 23389618. PubMed
  9. Glass DA 2nd, Bialek P, Ahn JD, et al. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell. 2005;8(5):751-764. doi:10.1016/j.devcel.2005.02.017. PMID: 15866165. PubMed
  10. Dallas SL, Prideaux M, Bonewald LF. The osteocyte: an endocrine cell … and more. Endocr Rev. 2013;34(5):658-690. doi:10.1210/er.2012-1026. PMID: 23612223. PubMed
  11. Seibel MJ. Biochemical markers of bone turnover: part I: biochemistry and variability. Clin Biochem Rev. 2005;26(4):97-122. PMID: 16648882. PubMed
  12. Garnero P. The Utility of Biomarkers in Osteoporosis Management. Mol Diagn Ther. 2017;21(4):401-418. doi:10.1007/s40291-017-0272-1. PMID: 28271451. PubMed
  13. Gohda J, Akiyama T, Koga T, Takayanagi H, Tanaka S, Inoue J. RANK-mediated amplification of TRAF6 signaling leads to NFATc1 induction during osteoclastogenesis. EMBO J. 2005;24(4):790-799. doi:10.1038/sj.emboj.7600564. PMID: 15678102. PubMed
  14. Vaananen HK, Zhao H, Mulari M, Halleen JM. The cell biology of osteoclast function. J Cell Sci. 2000;113(Pt 3):377-381. PMID: 10639325. PubMed
  15. Krishnan V, Bryant HU, MacDougald OA. Regulation of bone mass by Wnt signaling. J Clin Invest. 2006;116(5):1202-1209. doi:10.1172/JCI28551. PMID: 16670761. PubMed
  16. Li X, Zhang Y, Kang H, Liu W, Liu P, Zhang J, Harris SE, Wu D. Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J Biol Chem. 2005;280(20):19883-19887. doi:10.1074/jbc.M413274200. PMID: 15778503. PubMed